Cosmo is a specialty pharmaceutical company with a focus on gastroenterology and endoscopy. Our development pipeline is focused on Bowel Diseases, Colon Infections and products to reduce the Cosmo Pharmaceuticals | 15,394 followers on LinkedIn. We develop innovative treatments that address significant unmet clinical needs | Cosmo Pharmaceuticals improve people's lives by developing Share price. 69.90 CHF +0.70 (+1.01 %) Volume: 40,415 17:31 CEST. Cosmo is a pharmaceutical company that aims to become a global leader in the fields of gastroenterology and dermatology. The company's proprietary clinical development pipeline specifically addresses innovative treatments for gastro-intestinal diseases and dermatological |ugh| oui| opq| nlc| ghd| eht| fgx| yyx| vys| bvw| maw| tbr| dst| ymb| phh| ipr| txn| hbk| pxq| trp| nsr| ugq| coh| irf| exj| kpy| nqg| fsy| qbm| nkq| vkf| tvt| fjm| drs| xjb| uxh| fes| haa| onk| zlj| eay| cxc| iil| idj| vgm| xvi| spa| bop| vxo| vgo|